Aurinia Pharmaceuticals Inc (AUPH)

Finanzdaten der Aurinia Pharmaceuticals Inc-Aktie (AUPH)

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2026-09-30	2026-06-30	2026-03-31	2025-12-31	2025-09-30
Periodenlänge	3 Monate	3 Monate	3 Monate	3 Monate	3 Monate
Revenues	0.58%83.70	83.22	77.71	77.11	73.47
Cost Of Revenue	26.71%8.31	6.56	6.51	8.80	8.18
	27.30%16.61	13.05	7.47	-	-
Research and Development	27.30%16.61	13.05	7.47	-	-
Costs And Expenses	31.07%48.34	36.88	36.28	43.88	43.72
Operating Income/Loss	23.69%35.36	46.34	41.42	33.24	29.75
Income/Loss From Continuing Operations Before Tax	20.64%38.72	48.79	43.93	77.11	31.96
Income Tax Expense/Benefit, Deferred	25.45%8.28	11.11	9.28	-	-
Income Tax Expense/Benefit	38.34%7.01	11.37	9.57	-175.10	0.41
	15.26%31.70	37.41	34.36	210.79	31.55
Attributable To Parent	15.26%31.70	37.41	34.36	210.79	31.55
Basic Average Shares	2.58%133.43	130.08	132.38	-0.80	131.81
Diluted Average Shares	1.23%135.17	133.53	137.64	-0.26	136.01
Basic Earnings Per Share	17.24%0.24	0.29	0.26	1.60	0.24
Diluted Earnings Per Share	17.86%0.23	0.28	0.25	1.53	0.23